About Pedra
Pedra is a company based in Singapore (Singapore) founded in 2013. Pedra has raised $4.7 million across 2 funding rounds from investors including M&L Group, SEEDS Capital and NTUitive. Pedra offers products and services including Xauron Perfusion System. Pedra operates in a competitive market with competitors including Podimetrics, VOTIS, Thermetrix, Mimosa Diagnostics and Celsius Health, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Pedra Technology Pte. Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.7 M (USD)
in 2 rounds
-
Latest Funding Round
$4.7 M (USD), Series A
Sep 22, 2020
-
Investors
M&L Group
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pedra
Pedra offers a comprehensive portfolio of products and services, including Xauron Perfusion System.
Provides real-time quantitative monitoring for tissue perfusion in medical procedures
Funding Insights of Pedra
Pedra has successfully raised a total of $4.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.7 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pedra
Pedra has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include M&L Group, SEEDS Capital and NTUitive.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family investment firm based in Singapore, diversified across sectors.
|
Locked | Locked | Locked | |
|
Government-backed fund investing in tech startups
|
Locked | Locked | Locked | |
|
Startups across technologies and sectors are incubated by university-backed NTUitive.
|
Locked | Locked | Locked |
Investor details for Pedra
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pedra
Investment portfolio details for Pedra
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pedra
Detailed financials for Pedra
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pedra Comparisons
Peer comparison for Pedra
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pedra
Pedra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Podimetrics, VOTIS, Thermetrix, Mimosa Diagnostics and Celsius Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diabetic foot ulcer monitoring device for patients and doctors
|
|
| Locked | Locked | Locked |
AI-based device and platform for diagnosing diabetic patient feet
|
|
| Locked | Locked | Locked |
Medical device design and development company
|
|
| Locked | Locked | Locked |
Early foot ulcer detection is facilitated by non-invasive mHealth technology.
|
|
| Locked | Locked | Locked |
Develops innovative devices for managing diabetic foot ulcers.
|
Detailed competitors of Pedra
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pedra
Complete news archive for Pedra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pedra
Pedra was founded in 2013.
Pedra is headquartered in Singapore, Singapore.
Kareen Looi is the current CEO of Pedra.
Pedra is a funded company, having raised a total of $4.7M across 2 funding rounds to date.
Pedra was founded in 2013 in Singapore as a medical technology company. Tissue perfusion monitoring technology is provided by the firm for diagnosing and treating diabetic foot ulcers, critical limb ischemia, peripheral arterial disease, and chronic wounds. Operations focus on healthcare devices that assess blood flow in tissues, with applications in vascular medicine and wound management across clinical settings.
Pedra's top competitors include Podimetrics, VOTIS and Mimosa Diagnostics.
Pedra offers Xauron Perfusion System.
Pedra has 3 investors. Key investors include M&L Group, SEEDS Capital, and NTUitive.